Brokerages expect Apyx Medical Corp (NASDAQ:APYX) to announce ($0.18) earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Apyx Medical’s earnings, with estimates ranging from ($0.18) to ($0.17). Apyx Medical posted earnings of ($0.03) per share in the same quarter last year, which would suggest a negative year over year growth rate of 500%. The firm is scheduled to announce its next earnings results after the market closes on Wednesday, May 8th.

According to Zacks, analysts expect that Apyx Medical will report full year earnings of ($0.71) per share for the current year, with EPS estimates ranging from ($0.73) to ($0.68). For the next fiscal year, analysts anticipate that the business will post earnings of ($0.72) per share, with EPS estimates ranging from ($0.76) to ($0.68). Zacks’ EPS averages are a mean average based on a survey of research firms that that provide coverage for Apyx Medical.

Apyx Medical (NASDAQ:APYX) last issued its quarterly earnings data on Wednesday, March 13th. The company reported ($0.10) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.10). Apyx Medical had a net margin of 206.55% and a negative return on equity of 8.95%. The firm had revenue of $5.93 million for the quarter, compared to the consensus estimate of $5.95 million. During the same quarter in the previous year, the firm earned ($0.09) EPS. The company’s quarterly revenue was up 62.0% compared to the same quarter last year.

A number of research analysts have recently issued reports on the stock. ValuEngine downgraded shares of Apyx Medical from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, April 3rd. Dougherty & Co dropped their target price on shares of Apyx Medical from $12.00 to $9.00 and set a “buy” rating on the stock in a research report on Tuesday, April 2nd. JMP Securities dropped their target price on shares of Apyx Medical from $12.00 to $8.00 and set a “market outperform” rating on the stock in a research report on Tuesday, April 2nd. Zacks Investment Research downgraded shares of Apyx Medical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 18th. Finally, Piper Jaffray Companies boosted their target price on shares of Apyx Medical to $10.00 and gave the stock an “overweight” rating in a research report on Monday, February 11th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $9.00.

A hedge fund recently bought a new stake in Apyx Medical stock. Tibra Equities Europe Ltd bought a new stake in shares of Apyx Medical Corp (NASDAQ:APYX) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 58,453 shares of the company’s stock, valued at approximately $369,000. Tibra Equities Europe Ltd owned 0.17% of Apyx Medical as of its most recent filing with the Securities and Exchange Commission. 39.93% of the stock is owned by institutional investors.

Shares of Apyx Medical stock traded up $0.18 on Friday, reaching $3.85. The stock had a trading volume of 517,553 shares, compared to its average volume of 630,456. Apyx Medical has a 1 year low of $3.32 and a 1 year high of $8.89. The company has a market cap of $131.05 million, a P/E ratio of -13.28 and a beta of 0.36.

Apyx Medical Company Profile

Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.

Further Reading: How to calculate the intrinsic value of a stock

Get a free copy of the Zacks research report on Apyx Medical (APYX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Apyx Medical (NASDAQ:APYX)

Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.